Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Ajinomoto Althea, Inc.
EIR
•Ajinomoto Althea, Inc.•May 18, 2015

Ajinomoto Althea, Inc. – FDA EIR, May 18, 2015

Record Details

The FDA conducted a Pre-Approval and Current Good Manufacturing Practice (cGMP) inspection of Ajinomoto Althea, Inc., a contract manufacturer of sterile drug products in San Diego, CA, from May 6 to May 18, 2015. The inspection covered specific drug product applications, (b)(4) and (b)(4), for which the company performs fill/finish and some release testing. This inspection followed established FDA guidelines for biological therapeutic drug products and pre-approval inspections. At the conclusion of the inspection, a two-item FDA-483 was issued, detailing cGMP deficiencies. The primary violations included the practice of transferring formulated bulk drug product from classified cleanroom environments to unclassified refrigerated storage and back into the cleanroom for filling without implementing an additional filtration step. A second observation pertained to the inadequate material qualification of specific manufacturing bags ((b)(4) bags). Company management acknowledged the deficiencies and immediately began corrective actions during the inspection. They committed to submitting a formal written response to the FDA-483 within 15 days. Additionally, several operational discussion points were communicated, including the need for media fills to accurately reflect production processes, consistent review of cleanroom pressure differential data, and timely closure of Out-of-Tolerance investigations, to which management also promised corrections.

Company
Ajinomoto Althea, Inc.
Inspection date
May 18, 2015
Product type
biologics
Office
Los Angeles District Office
Person
  • Joey V. Quitania (Public Affairs Specialist)
View Company Profile

ID · 0bed48cf-207e-450b-bceb-5bb45fd3e4d9

Violation Codes5
21 CFR 211.113(b)21 CFR 820.3021 CFR 820.10021 CFR 820.5021 CFR 211.84(d)(2)

Full citation text and observation details available on the Dashboard.

Other documents for Ajinomoto Althea, Inc.
  • 483 - 2025-05-09May 9, 2025
  • 483 - 2023-09-20September 20, 2023
  • 483 - 2023-02-09February 9, 2023
  • 483 - 2023-01-16January 16, 2023
  • 483 - 2021-05-25May 25, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ajinomoto Althea, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.